In accordance with Section 287(a) of Title 35 of the United States Code, the following list identifies Nabriva’s rights associated with the relevant product(s). This list may be updated from time to time to add newly issued patents or remove expiring patents.
|
Product
|
Patent Number
|
|
Lefamulin
|
US6,753,445; US8,071,643; US8,153,689; US9,120,727
|
PDF version - Patents